Figure 1From: Impact of methylene blue and atorvastatin combination therapy on the apparition of cerebral malaria in a murine model Survival curve of C57Bl6/N mice infected on day 0 (D0) with Plasmodium berghei ANKA parasites and treated with 40 mg/kg atorvastatin (AVA) for seven days, 10 mg/kg Proveblue® for five days or 40 mg atorvastatin for seven days combined with 10 mg/kg Proveblue® for five days. Back to article page